Health/Trend |
|
|
|
12ÀÏ Á¾·Î±¸ º¸·Éºôµù¿¡¼ ÁøÇàµÈ ¡®HAPPY ÇåÇ÷µ¥ÀÌ¡¯¿¡¼ º¸·ÉÁ¦¾à±×·ì ÀÓÁ÷¿øµéÀÌ ÇåÇ÷À» ÇÏ°í ÀÖ´Ùº¸·ÉÁ¦¾à±×·ìÀÌ ÀÓÁ÷¿øÀ» ´ë»óÀ¸·Î ¡°HAPPY ÇåÇ÷µ¥ÀÌ¡± Ä·ÆäÀÎÀ» ÁøÇàÇß´Ù. ¡°HAPPY ÇåÇ÷µ¥ÀÌ¡± Ä·ÆäÀÎÀº º¸·ÉÁ¦¾à±×·ìÀÇ ÀÓÁ÷¿ø Âü¿© »çȸ°øÇåÈ°µ¿À¸·Î ¿ÃÇØ 10³â°¸¦ ¸Â¾Ò´Ù. ¿ÃÇØ´Â Áö³ 9ÀÏ ¾È»ê°øÀåÀ» ¡¦
|
|
|
24ÀÏ Á¾·Î±¸ º¸·Éºôµù¿¡¼ ÁøÇàµÈ È£Áß±¸°¨¼ÒÁõÄ¡·áÁ¦ ¡®´º¶óÆ塯 °øµ¿ÆǸŠ°è¾à½Ä¿¡¼ º¸·ÉÁ¦¾à ÀÌ»ï¼ö´ëÇ¥(¿ÞÂÊ), GC³ì½ÊÀÚ ÇãÀºÃ¶ ´ëÇ¥(¿À¸¥ÂÊ)°¡ ¼¸í½ÄÀ» ¸¶Ä¡°í ±â³ä»çÁøÀ» Âï°íÀÖ´Ù.º¸·ÉÁ¦¾àÀº GC³ì½ÊÀÚ¿Í Áö³ 24ÀÏ Á¾·Î±¸ º¸·Éºôµù¿¡¼ È£Áß±¸°¨¼ÒÁõÄ¡·áÁ¦ ¡®´º¶óÆ塯ÀÇ °øµ¿ÆǸŠ°è¾à½ÄÀ» ÁøÇàÇß´Ù°í 25ÀÏ ¹àÇû´Ù¡¦
|
|
11ÀÏ ½ºÆäÀÎ ¸¶µå¸®µå ÀÌÆ丶 ÄÁº¥¼Ç¼¾ÅÍ¿¡¼ °³ÃÖµÈ ¼¼°èÀǾàÇ°Àü½Ãȸ ÇöÀå¿¡¼ ÁøÇà µÈ °è¾à ¼¸í½Ä¿¡¼ º¸·ÉÁ¦¾à ±Û·Î¹ú¼¼ÀÏÁîÆÀ ¾È¿µ¹Î ´ë¸®, Çѱ¹ÀǾàÇ°¼öÃâÀÔÇùȸ ¿ÀÀå¼® ȸÀå, º¸·ÉÁ¦¾à ±Û·Î¹ú¼¼ÀÏÁîÆÀ ¹ÚÀç·Ï ÀÌ»ç, Àεà¾î¸ÞµðÄ® Á¶³ª½º ¾È°¡¶ó µöÆĶô(Jonas angara Depalac) ¾àÁ¦ÃÖ°íÃ¥ÀÓÀÚ(chief pharmacist, Hea¡¦
|
|
Áö³ 22ÀÏ Áß±¹ º£ÀÌ¡ ÀÎÅͳ׼ųΠÄÁº¥¼Ç¼¾ÅÍ¿¡¼ °³ÃÖµÈ 2018¼¼°è°íÇ÷¾ÐÇÐȸ ¡®ÇǸ¶»ç¸£Åº ½ÉÆ÷Áö¾ö¡¯¿¡¼ ¿¬¼¼´ë ¹Ú¼ºÇÏ ±³¼ö°¡ ¡®°íÇ÷¾Ð °ü¸®¿¡¼ ÇǸ¶»ç¸£Åº/¾Ï·ÎµðÇÉ(µàÄ«ºê) ´ÜÀÏÁ¤ º¹ÇÕÁ¦ÀÇ À¯ÀÍÇÑ È¿°ú¡¯¶ó´Â ÁÖÁ¦·Î µàÄ«ºê ÀÓ»ó ½ÃÇè °á°ú¸¦ ¼Ò°³ÇÏ°í ÀÖ´Ù. º¸·ÉÁ¦¾à(´ëÇ¥ ÃÖÅÂÈ«)ÀÌ Áö³ 20ÀϺÎÅÍ 23ÀϱîÁö¡¦
|
|
8¿ù 8ÀÏ º¸·ÉÁ¦¾à º»»ç¿¡¼ ÁøÇàµÈ ³×½ºÇÁ ¹× ·¹±×ÆĶó ÄÚÇÁ·Î¸ð¼Ç °è¾à½Ä¿¡¼ º¸·ÉÁ¦¾à ÃÖÅÂÈ« »çÀå (¿ÞÂÊ)°ú Çѱ¹Äì¿ÍÇÏÄڱ⸰ ³ªÁ¾Ãµ »çÀå (¿À¸¥ÂÊ)ÀÌ °è¾à¼¿¡ ¼¸í ÈÄ ¾Ç¼ö¸¦ ÇÏ°í ÀÖ´Ù.¡®º¸·ÉÁ¦¾à(»çÀå ÃÖÅÂÈ«)¡¯°ú ¡®Çѱ¹Äì¿ÍÇÏÄڱ⸰ (»çÀå ³ªÁ¾Ãµ)¡¯Àº 9¿ù 1ÀϺÎÅÍ ¸¸¼º½ÅÀ庴(CKD)ȯÀÚ¿¡¼ ³ªÅ¸³ª´Â ºóÇ÷¿¡ ´ëÇÑ ¡¦
|
|
Dignitaries, including Boryung Pharmaceutical Group Kim Seung-ho, Boryung Pharmaceutical President Choi Tae-hong, Zuellig Pharma Senior Vice President George Eassey, and John Hoeft, vice president of marketing excellence at ZuelligPharman. attend a ceremony to launch Kanarb in Singapore on July 28. ¡¦
|
|
President Lee Woo-suk of Kolon Tissue Gene speaks at a news conference at the Kolon One & Only Tower in Magok-dong, western Seoul, on July 10 to celebrate the nation¡¯s approval of ¡°Invossa,¡± Korea¡¯s first gene-therapy drug for treating osteoarthritis. (Photos: Kolon Group)¡°If Invossa, Korea¡¦
|
|
Boryung Pharmaceutical Group Chairman Kim Seung-ho, Boryung Pharmaceutical President Choi Tae-hong, and President Choi Sung-joon of Boryung Pharmaceutical Seoul Research Institute, along with other executives and staff, participate in a ceremony to celebrate the fifth anniversary of the establishmen¡¦
|
|
Director Paik Nam-sun of Ewha Womans¡¯ University Cancer Center for Women, who chairs a session on healthy aging life habits and health changes, part of an academic seminar, sponsored by the Healthy Aging Society. (Photo: Director Paik Nam-sun of Ewha Womans¡¯ University Cancer Center for Women)A vi¡¦
|
|
11¿ù 30ÀÏ aT¿¡¼ °³ÃÖµÈ ´ëÇѹα¹ ½ÄÇ°¹Ú¶÷ȸ¿¡ ´ëÇѹα¹ õ³âÃÊ ¸í°¡ ³ó¾÷¹ýÀÎ ÁÖ½Äȸ»ç ºÀȲÀÌ Àü½Ãȸ¿¡ Âü°¡ÇÏ¿© ¼ÒºñÀڵ鿡°Ô ¸¹Àº È£ÀÀÀ» ¾ò¾ú´Ù.ºÀȲÀº °æ³² »êû±º Áö¸®»ê ûÁ¤Áö¿ª¿¡¼ À¯±â³ó Àç¹è¹æ½ÄÀ¸·Î õ³âÃʸ¦ Á÷Á¢ Àç¹è ¹× °¡°ø»ý»êÀ» ÇÏ°í ÀÖ´Â À¯¸ÁÇÑ ³ó¾÷¹ýÀÎÀÌ´Ù.Á¤ºÎ¿Í »êû±º¿¡¼´Â ³ó¾÷ÀÇ¡¦
|
|
|
|
´ëÇÑÇ×°øÀÌ ¾Æ½Ã¾Æ³ªÇ×°ø°úÀÇ ±â¾÷°áÇÕÀ» À§ÇØ EU °æÀï´ç±¹ÀÌ Á¦½ÃÇÑ Á¶°ÇºÎ ½ÂÀÎÀÇ ¼±Çà Á¶°ÇÀ» ¸ðµÎ ÃæÁ·½ÃÄ×´Ù.EU °æÀï´ç±¹(European Commission¡¤EC)Àº ÇöÁö½Ã°£ 11¿ù 28ÀÏ(¸ñ) ´ëÇÑÇ×°ø°ú ¾Æ½Ã¾Æ³ªÇ×°øÀÇ °áÇÕÀ» À§ÇÑ ¼±°á ¿ä°ÇÀÌ ¸ðµÎ ¡®ÃæÁ·¡¯µÅ ½É»ç¸¦ Á¾°áÇÑ´Ù¡¦
|
|
¡ã Çö´ë¸ðºñ½º À̱Լ® »çÀåÀÌ 11¿ù 19ÀÏ ¿©Àǵµ Æä¾î¸óÆ® È£ÅÚ¿¡¼ ¿¸° ¡®2024 CEO Àκ£½ºÅÍ µ¥ÀÌ¡¯ ¹ßÇ¥ÀÚ·Î ³ª¼ »ç¾÷ ¹æÇ⼺°ú Àü·«À» ¹ßÇ¥ÇÏ°í ÀÖ´Ù. Çö´ë¸ðºñ½º°¡ ±Û·Î¹ú ¼±µµ±â¼ú °æÀï·ÂÀ» ¹ÙÅÁÀ¸·Î ¼öÀͼº Á᫐ »ç¾÷üÁú °³¼±¿¡ ³ª¼±´Ù. À̸¦ ÅëÇØ 20¡¦
|
|
Çö´ëÀÚµ¿Â÷±×·ìÀº ¿µ±¹ À¯·Â ÀÚµ¿Â÷ Àü¹® ¸Åü ž±â¾î(Top Gear)°¡ ÁÖ°üÇÏ´Â ¡®2024 ž±â¾î ¾î¿öÁî(2024 TopGear.com Awards)¡¯¿¡¼ Çö´ëÀÚµ¿Â÷ ½ÑŸÆä°¡ ¡®¿ÃÇØÀÇ SUV(SUV of the Year)¡¯¿¡ ±â¾Æ EV3°¡ ¡®¿ÃÇØÀÇ Å©·Î½º¿À¹ö(Crossover of the Year)¡¯¿¡ °¢°¢ ¿À¸£¸ç 4¡¦
|
|
¢ßÇÑÈ´Â 10¿ù 25ÀÏ ¼öÈ®±â¸¦ ¸ÂÀÌÇÑ ³ó°¡¸¦ ¹æ¹®ÇØ ¡®ÀÓÁ÷¿ø°ú ÇÔ²²ÇÏ´Â ³óÃÌ Àϼյ½±â ºÀ»çÈ°µ¿¡¯À» ½Ç½ÃÇß´Ù.¢ßÇÑÈ¿Í ³óÇùÁß¾Óȸ°¡ Çù¾÷ÇÑ À̹ø ºÀ»çÈ°µ¿Àº Àα¸°¨¼Ò¿Í °í·ÉÈ·Î ¾î·Á¿òÀ» °Þ°í ÀÖ´Â ³óÃÌ Áö¿ªÀ» Áö¿øÇϱâ À§ÇØ ¸¶·ÃµÆ´Ù. ¢ßÇÑÈ ÀÓÁ÷¿ø ÃÑ 30¿©¸íÀº¡¦
|
|
|